Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for InMode Ltd. (INMD : NSDQ)

• Company Description    InMode Ltd. is a provider of medical technologies. It develops, manufactures and markets devices harnessing novel radio-frequency technology. The company serves plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology. InMode Ltd. is based in Yokneam, Israel. Number of Employees: 660

• Price / Volume Information    Yesterday's Closing Price: $14.91 Daily Weekly Monthly 20 Day Moving Average: 436,607 shares Shares Outstanding: 57.48 (millions) Market Capitalization: $857.04 (millions) Beta: 1.86 52 Week High: $16.74 52 Week Low: $12.72 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -2.61% -2.12% 12 Week 10.85% 6.73% Year To Date 1.50% -9.98%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL TAVOR BUILDING SHAAR YOKNEAM POB 533 - YOKNEAM,L3 2069200 ISR ph: 972-4909-7470 fax: - ir@inmodemd.com http://www.inmodemd.com

• General Corporate Information    Officers Moshe Mizrahy - Chief Executive Officer Michael Anghel - Chairman Yair Malca - Chief Financial Officer Michael Kreindel - Chief Technology Officer and Director Hadar Ron - Director Peer Information InMode Ltd. (BJCT) InMode Ltd. (CADMQ) InMode Ltd. (APNO) InMode Ltd. (UPDC) InMode Ltd. (IMTIQ) InMode Ltd. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: M5425M103 SIC: 3845 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/04/26 Share - Related Items Shares Outstanding: 57.48 Most Recent Split Date: 10.00 (2.00:1) Beta: 1.86 Market Capitalization: $857.04 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/04/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 11.93 PEG Ratio: - Price Ratios Price/Book: 1.36 Price/Cash Flow: 9.99 Price / Sales: 2.29 EPS Growth vs. Year Ago Period: -30.95% vs. Previous Quarter: 45.00% Sales Growth vs. Year Ago Period: -0.01% vs. Previous Quarter: 16.55% ROE 06/30/26 - 11.99 03/31/26 - 13.47 12/31/25 - 14.52 ROA 06/30/26 - 10.60 03/31/26 - 11.95 12/31/25 - 12.88 Current Ratio 06/30/26 - 8.18 03/31/26 - 8.80 12/31/25 - 9.88 Quick Ratio 06/30/26 - 7.28 03/31/26 - 7.88 12/31/25 - 8.83 Operating Margin 06/30/26 - 21.03 03/31/26 - 23.61 12/31/25 - 25.33 Net Margin 06/30/26 - 20.69 03/31/26 - 23.27 12/31/25 - 25.33 Pre-Tax Margin 06/30/26 - 24.28 03/31/26 - 27.28 12/31/25 - 29.78 Book Value 06/30/26 - 10.94 03/31/26 - 10.44 12/31/25 - 10.78 Inventory Turnover 06/30/26 - 1.22 03/31/26 - 1.17 12/31/25 - 1.15 Debt-to-Equity 06/30/26 - 0.00 03/31/26 - 0.00 12/31/25 - 0.00 Debt-to-Capital 06/30/26 - 0.00 03/31/26 - 0.00 12/31/25 - 0.00

Powered by Zacks Investment Research ©